FRESENIUS MEDICAL CA

FME
Delayed Quote. Delayed  - 07/01 11:35:00 am
47.58EUR -0.10%

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : UBS maintains a Buy rating

06/23/2022 | 07:12am
In his latest research note, analyst Graham Doyle confirms his positive recommendation. The broker UBS is keeping its Buy rating. The target price remains unchanged at EUR 75.
© MarketScreener with dpa-AFX Analyser 2022
Copier lien
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
6d ago
6d ago
6d ago
06/23
06/23